The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
Open accessAbstract
IntroductionGraft-versus-host disease (GVHD) is one of the major complications of allogeneic bone marrow transplantation and blood transfusion (1).GVHD is initiated by donor T cells specific against the host antigens (1-3).Acute GVHD is a rapidly progressing systemic illness characterized by immunosuppression and tissue injury in various organs, including liver, skin, and intestinal mucosa (1-7).Especially in the liver, GVHD is characterized by portal hepatitis, nonsuppurative destructive cholangitis (NSDC), cholestasis, and endotheliitis (1,2,8).Although the molecular pathogenesis of GVHD remains to be uncovered, there is general agreement that infiltrating T lymphocytes play a central role (3-5, 7, 9, 10).Previous studies have shown that in parent-into-F1 models, acute GVHD is characterized by a severe reduction in host lymphocytes and a profound immunodeficiency due to the activation of both donor CD4 + and CD8 + T cell subsets in response to host alloantigens (3, 11, 12).Early events that favor the development of acute GVHD are engraftment of CD8 + T cells and production of IFN-γ by donor CD4 + T cells (3, 12).However, these studies were carried out in the spleen, not in main target organs such as liver, skin, and intestine.In addition, recent studies suggest that both perforin-and Fas-mediated pathways are involved in the systemic signs of GVHD, and epithelial cell injury in liver, skin, and intestine appears to be Fas-mediated (4-6, 9, 10).These observations led us to investigate the main target organ, the liver, which has a pivotal role in maintaining homeostasis.Leukocyte migration is a multistep process involving the sequential activation of various adhesion molecules located on the immune cells and the vascular endothelium, as well as a vast array of chemo-kines and their receptors (13-17).The involvement of chemokines and their receptors in inflammation has been elucidated during the last several years (18-23), but their functional roles in the progression of various diseases are not yet fully understood.In light of the recruitment of alloreactive T lymphocytes to a specific tissue site in GVHD, we focused on the characterization of chemokine receptors on these key lymphocytes and investigated the role of these cells in the pathogenesis of liver injury in a murine GVHD model. MethodsAnimals.C57BL/6 mice (B6, H-2 b ) were used as donors, and (B6 × DBA/2)F1 mice (BDF1, H-2 b×d ) were used as
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
A novel method for real time quantitative RT-PCR.
Gibson, U. E., Heid, C. A., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.995 · Cited by 2,075
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Ferrara, J. L. M., & Deeg, H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241005 · Cited by 1,219
CCR5 is characteristic of Th1 lymphocytes
Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., & Dayer, J.-M. (1998) · Nature · doi:10.1038/34814 · Cited by 866
Mig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., & Kelvin, D. J. (1993) · Science · doi:10.1126/science.7682337 · Cited by 730
Cited by
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Jia, H. P., Look, D. C., Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S., & McCray, P. B. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14614-14621.2005 · Cited by 949
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationLymphoid Neogenesis in Rheumatoid Synovitis
Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O’Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1072 · Cited by 660
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C., Cooke, K. R., & Ferrara, J. L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-575 · Cited by 521
Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation
Welniak, L. A., Blazar, B. R., & Murphy, W. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141606 · Cited by 520
Pathophysiology of Graft-Versus-Host Disease
Ferrara, J. L. M., & Reddy, P. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.09.001 · Cited by 363
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M., Gakhar, L., Chappell, M. C., Wohlford-Lenane, C., & McCray, P. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2009 · Cited by 329
Leukocyte migration and graft-versus-host disease
Wysocki, C. A., Panoskaltsis-Mortari, A., Blazar, B. R., & Serody, J. S. (2005) · Blood · doi:10.1182/blood-2004-12-4726 · Cited by 316
Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
Adams, D. H., & Eksteen, B. (2006) · Nature Reviews Immunology · doi:10.1038/nri1784 · Cited by 307
Mechanisms of Immune-Mediated Liver Injury
Adams, D. H., Ju, C., Ramaiah, S. K., Uetrecht, J., & Jaeschke, H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq009 · Cited by 298
Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction
Murai, M., Yoneyama, H., Ezaki, T., Suematsu, M., Terashima, Y., Harada, A., Hamada, H., Asakura, H., Ishikawa, H., & Matsushima, K. (2003) · Nature Immunology · doi:10.1038/ni879 · Cited by 290
Self-citationBolaños-Meade, J., Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(18)30221-7 · Cited by 287
Lampson, B. L., Kasar, S. N., Matos, T. R., Morgan, E. A., Rassenti, L., Davids, M. S., Fisher, D. C., Freedman, A. S., Jacobson, C. A., Armand, P., et al. (2016) · Blood · doi:10.1182/blood-2016-03-707133 · Cited by 285
Shi, K., Hayashida, K., Kaneko, M., Hashimoto, J., Tomita, T., Lipsky, P. E., Yoshikawa, H., & Ochi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.650 · Cited by 280
Yi, T., Chen, Y., Wang, L., Du, G., Huang, D., Zhao, D., Johnston, H., Young, J., Todorov, I., Umetsu, D. T., et al. (2009) · Blood · doi:10.1182/blood-2009-05-219402 · Cited by 280
Acute graft-versus-host disease: from the bench to the bedside
Socié, G., & Blazar, B. R. (2009) · Blood · doi:10.1182/blood-2009-06-204669 · Cited by 262
Grant, A. J., Lalor, P. F., Salmi, M., Jalkanen, S., & Adams, D. H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07374-9 · Cited by 255
Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease
Reshef, R., Luger, S. M., Hexner, E. O., Loren, A. W., Frey, N. V., Nasta, S. D., Goldstein, S. C., Stadtmauer, E. A., Smith, J., Bailey, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201248 · Cited by 254
Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy
Gough, M., Crittenden, M., Thanarajasingam, U., Sanchez-Perez, L., Thompson, J., Jevremovic, D., & Vile, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5766 · Cited by 60
“CCR5 is expressed on the effector-effector/memory population (6, 40, 41) and this interaction is known to be critical for control of T cell responses in a number of models (4–6, 31).”
Background
Metadata
- Authors
- Murai, M., Yoneyama, H., Harada, A., Yi, Z., Vestergaard, C., Guo, B., Suzuki, K., Asakura, H., & Matsushima, K.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-07-01
- Volume
- 104
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1964616348
- Cited by
- 301
- References
- 33
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.